Fig. 1From: Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabineThe panniculitis-like lesions with adjacent erythematous patches and skin ulcerationBack to article page